Spots Global Cancer Trial Database for lycopene
Every month we try and update this database with for lycopene cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients | NCT01882985 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Docetaxel Lycopene | 21 Years - | University of California, Irvine | |
Lycopene in Preventing Prostate Cancer in Healthy Participants | NCT00093561 | Prostate Cancer | lycopene | 18 Years - 45 Years | National Cancer Institute (NCI) | |
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer | NCT00450749 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... Stage III Prost... | placebo therapeutic con... laboratory biom... lycopene | 18 Years - | National Cancer Institute (NCI) | |
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance | NCT00744549 | Cancer of the P... Prostate Cancer Prostatic Neopl... | Lycopene, Vitam... Placebo | 18 Years - | University Health Network, Toronto | |
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer | NCT00844792 | Cancer of the P... Prostate Cancer Prostatic Neopl... | Lycopene, Vitam... Placebo | 18 Years - | University Health Network, Toronto | |
Lycopene In Preventing of Prostate Cancer | NCT00006078 | Prostate Cancer | lycopene | 18 Years - 45 Years | National Cancer Institute (NCI) | |
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer | NCT00450749 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... Stage III Prost... | placebo therapeutic con... laboratory biom... lycopene | 18 Years - | National Cancer Institute (NCI) | |
Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma | NCT00172367 | Carcinoma, Tran... | Lycopene | 18 Years - | National Taiwan University Hospital | |
Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma | NCT00172367 | Carcinoma, Tran... | Lycopene | 18 Years - | National Taiwan University Hospital | |
Lycopene in Treating Patients With Metastatic Prostate Cancer | NCT00068731 | Prostate Cancer | lycopene | 18 Years - | Alliance for Clinical Trials in Oncology | |
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance | NCT00744549 | Cancer of the P... Prostate Cancer Prostatic Neopl... | Lycopene, Vitam... Placebo | 18 Years - | University Health Network, Toronto | |
Lycopene in Healthy Male Participants | NCT00450957 | Healthy, no Evi... Prostate Cancer | lycopene pharmacological... | 18 Years - 55 Years | National Cancer Institute (NCI) | |
Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy | NCT00042731 | Prostate Cancer | Lycopene Multivitamin Soy isoflavones | 45 Years - 80 Years | H. Lee Moffitt Cancer Center and Research Institute | |
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients | NCT01882985 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Docetaxel Lycopene | 21 Years - | University of California, Irvine | |
Lycopene in Preventing Prostate Cancer in Healthy Participants | NCT00093561 | Prostate Cancer | lycopene | 18 Years - 45 Years | National Cancer Institute (NCI) | |
Panitumumab Skin Toxicity Prevention Trial | NCT03167268 | Colorectal Canc... Skin Toxicity | Lycopene Placebo | 18 Years - | Ospedale San Carlo Borromeo | |
Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer | NCT00416325 | Prostate Cancer | lycopene laboratory biom... | 35 Years - 75 Years | National Cancer Institute (NCI) | |
Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer | NCT00416325 | Prostate Cancer | lycopene laboratory biom... | 35 Years - 75 Years | National Cancer Institute (NCI) | |
Decipher Lethal Prostate Cancer Biology - Urine Metabolomics | NCT03237702 | Significant Pro... | Multi-Carotenoi... | 30 Years - 100 Years | National Taiwan University Hospital |